Phase 3 Readout
OSCR: Phase 3 Topline: Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a G
June 1, 2027. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- June 1, 2027
- Company
- Oscar Health Inc. (OSCR)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a G
- Company
- Oscar Health Inc. (OSCR)
- Indication
- Glioblastoma